Iranian Red Crescent Medical Journal (IRCMJ)

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Author Guidelines

Article Processing Charge

Cancer and COVID-19: A Double Burden on the Healthcare System

Document Type : Review articles

Authors

1 Department of Biology, Faculty of Science, University of Sistan and Baluchestan, Zahedan, Iran

2 Department of Biology, Faculty of Sciences, Shahid Bahonar University of Kerman, Kerman, Iran

Abstract

The COVID-19 pandemic has placed an unprecedented burden on the healthcare system. In particular, the intersection of COVID-19 and cancer has created a double burden on the healthcare system, presenting challenges in both the diagnosis and treatment of cancer. During the pandemic, overcrowding of hospitals and clinics, shortages of PPE and other medical supplies, and the impact of COVID-19 on healthcare workers have all made it more difficult to care for cancer patients. The challenges in cancer diagnosis and screening during the pandemic have included delays in cancer diagnoses, decreased access to cancer screenings, and a decrease in the number of cancer surgeries being performed. Changes in cancer treatment patterns and access to care during COVID-19 have also impacted the treatment outcomes for cancer patients, with a decrease in the number of cancer patients being treated and an increased risk of poor outcomes for those who are being treated. The impact of COVID-19 on healthcare workers and their ability to care for cancer patients has also been significant, with healthcare workers facing increased exposure to the virus, increased workloads, and increased stress and burnout. The double burden of COVID-19 and cancer on the healthcare system has implications for policy and practice, including the need for improved coordination between cancer and COVID-19 response efforts and the need for increased investment in healthcare infrastructure and resources. In conclusion, the COVID-19 pandemic has created a double burden on the healthcare system, with significant challenges in the diagnosis and treatment of cancer. The impact of COVID-19 on healthcare workers and the healthcare system more broadly highlights the need for improved coordination and increased investment in healthcare resources and infrastructure.

Keywords

References
  1. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021. doi:10.1002/ijc.33588. [PubMed:33818764]
  2. Eckerling A, Ricon-Becker I, Sorski L, Sandbank E, Ben-Eliyahu S. Stress and cancer: mechanisms, significance and future directions. Nat Rev Cancer. 2021;21(12):767-85. doi:10.1038/s41568-021-00395-5. [PMID:34508247]
  3. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48. doi:10.3322/caac.21763. [PubMed:36633525]
  4. Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat
  5. Rev Microbiol. 2022;20(5):270-84. doi:10.1038/s41579-022-00713-0
  6. Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141-54. doi: 10.1038/s41579-020-00459-7. [PubMed:33024307]
  7. Kumar A, Singh R, Kaur J, Pandey S, Sharma V, Thakur L, et al. Wuhan to world: the COVID-19 pandemic. Front Cell Infect Microbiol. 2021;11:596201. doi:10.3389/fcimb.2021.596201. [PubMed:33859951]
  8. Zong Z, Wei Y, Ren J, Zhang L, Zhou F. The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Mol Cancer. 2021;20(1):76. doi:10.1186/s12943-021-01363-1. [PubMed:34001144]
  9. Wang L, Sun Y, Yuan Y, Mei Q, Yuan X. Clinical challenges in cancer patients with COVID-19: aging, immunosuppression, and comorbidities. Aging. 2020;12(23):24462-74. doi: 10.18632/aging.104205. [PubMed:33232275]
  10. The Lancet. The COVID-19 pandemic in 2023: far from over. Lancet. 2023;401(10371):79. doi:10.1016/S0140-6736(23) 00050-8. [PubMed:36641201]
  11. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A review on the novel Coronavirus disease evolution, transmission, detection, control and prevention. Viruses. 2021;13(2):202. doi: 10.3390/v13020202. [PubMed:33572857]
  12. Shang Y, Li H, Zhang R. Effects of pandemic outbreak on economies: evidence from business history context. Front
  13. Public Health. 2021;9:632043. doi:10.3389/fpubh.2021.632043. [PubMed: 33777885]
  14. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-46. doi:10.1038/s41579-022-00846-2
  15. Proal AD, VanElzakker MB. Long COVID or post-acute Sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169. doi:10.3389/fmicb.2021.698169. [PubMed: 34248921]
  16. Rivas-Vazquez RA, Rey G, Quintana A, Rivas-Vazquez AA. Assessment and management of long COVID. J Health Serv Psychol. 2022;48(1):21-30. doi:10.1007/s42843-022-00055-8. [PubMed:35572152]
  17. Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(19):
  18. doi:10.3390/ijerph191912422. [PubMed:36231717]
  19. Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med. 2023;29(2):334-43. doi: 10.1038/s41591-022-02156-9. [PubMed:36797482]
  20. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. doi:10.3322/caac.21660. [PubMed:33538338]
  21. O’Brien K, Ried K, Binjemain T, Sali A. Integrative approaches to the treatment of cancer. Cancers. 2022;14(23):5933. doi:10.3390/cancers14235933. [PubMed:36497414]
  22. Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, et al. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 2015;35:S276-S304. doi:10.1016/j.semcancer.2015.09.007. [PubMed:26590477]
  23. Farhood B, Geraily G, Alizadeh A. Incidence and mortality of various cancers in Iran and compare to other countries: a review article. Iran J Public Health. 2018;47(3):309-16. [PubMed:29845017]
  24. Voigtländer S, Hakimhashemi A, Inwald EC, Ortmann O, Gerken M, Klug SJ, et al. The impact of the COVID-19 pandemic on cancer incidence and treatment by cancer stage in Bavaria, Germany. Dtsch Arztebl Int. 2021;118(39):660-1. doi: 10.3238/arztebl.m2021.0329. [PubMed:34919047]
  25. Rahimmanesh I, Shariati L, Dana N, Esmaeili Y, Vaseghi G, Haghjooy Javanmard S. Cancer occurrence as the upcoming complications of COVID-19. Front Mol Biosci. 2021;8:813175. doi: 10.3389/fmolb.2021.813175. [PubMed:35155571]
  26. Riera R, Bagattini ÂM, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol. 2021;7:311-23. doi:10.1200/GO.20.00639. [PubMed:33617304]
  27. Cancino RS, Su Z, Mesa R, Tomlinson GE, Wang J. The impact of COVID-19 on cancer screening: challenges and opportunities. JMIR Cancer. 2020;6(2):e21697. doi:10.2196/21697. [PMID: 33027039]
  28. Jidkova S, Hoeck S, Kellen E, le Cessie S, Goossens MC. Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators. BMC Cancer. 2022;22(1):183. doi:10.1186/s12885-022-09292-y. [PMID:35177021]
  29. Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of cancer screening deficit in the United States with the COVID-19 pandemic. JAMA Oncology. 2021;7(6):878-84. doi: 10.1001/jamaoncol.2021.0884. [PubMed:33914015]
  30. Kirby A, Drummond FJ, Lawlor A, Murphy A. Counting the social, psychological, and economic costs of COVID-19 for cancer patients. Support Care Cancer. 2022;30(11):8705-31. doi:10.1007/s00520-022-07178-0. [PubMed:35690662]
  31. Ng KYY, Zhou S, Tan SH, Ishak NDB, Goh ZZS, Chua ZY, et al. Understanding the psychological impact of COVID-19 pandemic on patients with cancer, their caregivers, and health care workers in Singapore. JCO Glob Oncol. 2020;6:1494-509. doi: 10.1200/GO.20.00374. [PMID:33017179]
  32. Gong Y, Liu X, Zheng Y, Mei H, Que J, Yuan K, et al. COVID-19 induced economic slowdown and mental health issues. Front Psychol. 2022;13:777350. doi: 10.3389/fpsyg.2022.777350. [PubMed:35310204]
  33. Fox L, Beyer K, Rammant E, Morcom E, Van Hemelrijck M, Sullivan R, et al. Impact of the COVID-19 pandemic on cancer researchers in 2020: a qualitative study of events to inform mitigation strategies. Front Public Health. 2021;9:741223. doi:10.3389/fpubh.2021.741223. [PubMed:34966713]
  34. Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative stress: harms and benefits for human
  35. health. Oxid Med Cell Longev. 2017;2017:8416763. doi: 10.1155/2017/8416763. [PubMed:28819546]
  36. Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44(5):479-96. doi:10.3109/10715761003667554. [PubMed:20370557]
  37. Cecchini R, Cecchini AL. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med Hypotheses. 2020;143:110102. doi: 10.1016/j.mehy.2020. 110102. [PubMed:32721799]
  38. Golabi S, Ghasemi S, Adelipour M, Bagheri R, Suzuki K, Wong A, et al. Oxidative Stress and Inflammatory Status in COVID-19 Outpatients: A Health Center-Based Analytical Cross-Sectional Study. Antioxidants. 2022;11(4): 606. doi: 10.3390/antiox 11040606. [PubMed:35453291]
  39. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010;4(8):118-26. doi:10.4103/0973-7847.70902. [PubMed:22228951]
  40. Kumar P, Kumar M, Bedi O, Gupta M, Kumar S, Jaiswal G, et al. Role of vitamins and minerals as immunity boosters in
  41. COVID-19. Inflammopharmacology. 2021;29(4):1001-16. doi: 10.1007/s10787-021-00826-7. [PubMed:34110533]
  42. Parikh KD, Ramaiya NH, Kikano EG, Tirumani SH, Pandya H, Stovicek B, et al. COVID-19 pandemic impact on decreased imaging utilization: a single institutional experience. Acad Radiol. 2020;27(9):1204-13. doi:10.1016/j.acra.2020.06.024. [PubMed:32665091]
  43. Bakouny Z, Hawley JE, Choueiri TK, Peters S, Rini BI, Warner JL, et al. COVID-19 and cancer: current challenges
  44. and perspectives. Cancer Cell. 2020;38(5):629-46. doi: 10.1016/j.ccell.2020.09.018. [PubMed:33049215]
  45. Alkatout I, Biebl M, Momenimovahed Z, Giovannucci E, Hadavandsiri F, Salehiniya H, et al. Has COVID-19 affected cancer screening programs? A systematic review. Front Oncol. 2021;11:675038. doi:10.3389/fonc.2021.675038. [PubMed: 34079764]
  46. Angelini M, Teglia F, Astolfi L, Casolari G, Boffetta P. Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis. Eur J Epidemiol. 2023;38(1):31-8. doi:10.1007/s10654-022-00946-6. [PubMed:36593334]
  47. Sahebi R, Akbari N, Bayat Z, Rashidmayvan M, Mansoori A, Beihaghi M. A Summary of Autophagy Mechanisms in Cancer Cells. Research in Biotechnology and Environmental Science. 2022;1(1):28-35.
  48. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi:10.1016/j.ijantimicag.2020.105949. [PubMed:32205204]
  49. Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The impact of the COVID-19 pandemic on cancer care. Nat Cancer. 2020;1(6):565-7. doi:10.1038/s43018-020-0074-y. [PubMed: 35121972]
  50. Fu R, Sutradhar R, Li Q, Hanna TP, Chan KKW, Irish JC, et al. Timeliness and modality of treatment for new cancer diagnoses during the COVID-19 pandemic in canada. JAMA Netw Open. 2023;6(1):e2250394. doi: 10.1001/jamanetwor kopen.2022.50394. [PubMed: 36626169]
  51. Pausawasdi N, Manomaiwong E, Kaosombatwattana U, Karaketklang K, Charatcharoenwitthaya P. The effects of COVID-19 on clinical outcomes of non-COVID-19 patients hospitalized for upper gastrointestinal bleeding during
  52. the pandemic. J Clin Med. 2022;11(9):2461. doi: 10.3390/jcm11092461. [PubMed:35566587]
  53. McGrowder DA, Miller FG, Vaz K, Anderson Cross M, Anderson-Jackson L, Bryan S, et al. The utilization and benefits of telehealth services by health care professionals managing breast cancer patients during the COVID-19 pandemic. Healthcare. 2021;9(10):1401. doi:10.3390/healthcare9101401. [PubMed:34683081]
  54. Ftouni R, AlJardali B, Hamdanieh M, Ftouni L, Salem N. Challenges of Telemedicine during the COVID-19 pandemic: a systematic review. BMC Med Inform Decis Mak. 2022;
  55. (1):207. doi:10.1186/s12911-022-01952-0. [PubMed: 35922817]
  56. Yang L, Chai P, Yu J, Fan X. Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants. Cancer Biol Med. 2021;18(1):298-307. doi: 10.20892/j.issn.2095-3941.2020.0559. [PubMed: 33628602]
  57. Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, et al. COVID-19 in cancer patients, risk factors for disease and adverse outcome, a population-based study from Norway. Front Oncol. 2021;11:652535. doi: 10.3389/fonc.2021.652535. [PMID: 33842366]
  58. Patt D, Gordan L, Diaz M, Okon T, Grady L, Harmison M, et al. Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors. JCO Clinical Cancer Informatics. 2020(4):1059-71.
  59. Al-Quteimat OM, Amer AM. The impact of the COVID-19 pandemic on cancer patients. Am J Clin Oncol. 2020;43(6):452-5. doi:10.1097/COC.0000000000000712. [PubMed:32304435]
  60. Sartini M, Carbone A, Demartini A, Giribone L, Oliva M, Spagnolo AM, et al. Overcrowding in emergency department: causes, consequences, and solutions; A narrative review. Healthcare. 2022;10(9):1625. doi: 10.3390/healthcare10091625. [PubMed: 36141237]
  61. Gatellier L, Shankar A, Dewi LKM, Hussain QM, Dendup Wangdi T, Sukumaran DB, et al. The impact of COVID-19 on cancer care in the post pandemic world: five major lessons learnt from challenges and countermeasures of major asian cancer centres. Asian Pac J Cancer Prev. 2021;22(3):681-90. doi: 10.31557/APJCP.2021.22.3.681. [PMID:33773529]
  62. Nnaji CA, Moodley J. Impact of the COVID-19 pandemic on cancer diagnosis, treatment and research in African health systems: a review of current evidence and contextual perspectives. Ecancermedicalscience. 2021;15:1170. doi: 10.3332/ecancer.2021.1170. [PubMed:33680084]
  63. Cohen J, Rodgers YVM. Contributing factors to personal protective equipment shortages during the COVID-19 pandemic. Prev
  64. Med. 2020;141:106263. doi: 10.1016/j.ypmed.2020.106263. [PubMed: 33017601]
  65. Shukar S, Zahoor F, Hayat K, Saeed A, Gillani AH, Omer S, et al. Drug shortage: causes, impact, and mitigation strategies. Front Pharmacol. 2021;12:693426. doi:10.3389/fphar.2021.693426. [PubMed:34305603]
  66. Gupta N, Dhamija S, Patil J, Chaudhari B. Impact of COVID-19 pandemic on healthcare workers. Ind Psychiatry J. 2021;
  67. (1):282-4. doi:10.4103/0972-6748.328830. [PubMed: 34908710]
  68. Nguyen LH, Drew DA, Joshi AD, Guo CG, Ma W, Mehta RS, et al. Risk of COVID-19 among frontline healthcare workers and the general community: a prospective cohort study. MedRxiv. 2020. doi: 10.1101/2020.04.29.20084111. [PubMed: 32511531]
  69. Aden D, Zaheer S, Raj S. Challenges faced in the cancer diagnosis and management-COVID-19 pandemic and beyond-Lessons for future. Heliyon. 2022;8(12):e12091. doi: 10.1016/j.heliyon.2022.e12091. [PubMed:36483302]
Iranian Red Crescent Medical Journal (IRCMJ)
Volume 25, Issue 2 - Serial Number 2
2023
Files
History
  • Receive Date: 13 February 2023
  • Revise Date: 20 May 2024
  • Accept Date: 27 January 2024
  • First Publish Date: 27 January 2024
  • Publish Date: 01 February 2023
Share
How to cite
Statistics